BRPI0416928A - desenvolvimento de derivados biologicamente ativos de azul de metileno - Google Patents

desenvolvimento de derivados biologicamente ativos de azul de metileno

Info

Publication number
BRPI0416928A
BRPI0416928A BRPI0416928-0A BRPI0416928A BRPI0416928A BR PI0416928 A BRPI0416928 A BR PI0416928A BR PI0416928 A BRPI0416928 A BR PI0416928A BR PI0416928 A BRPI0416928 A BR PI0416928A
Authority
BR
Brazil
Prior art keywords
biologically active
phenothiazine
compounds
methylene blue
conjugate
Prior art date
Application number
BRPI0416928-0A
Other languages
English (en)
Inventor
Stanley Beames Brown
Cassandra Claire O'grady
John Griffiths
Kirste Joanne Mellish
Richard George Tunstall
David John Howard Roberts
David Ian Vernon
Original Assignee
Photopharmica Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB0327672.2A external-priority patent/GB0327672D0/en
Priority claimed from GB0329809A external-priority patent/GB0329809D0/en
Application filed by Photopharmica Ltd filed Critical Photopharmica Ltd
Publication of BRPI0416928A publication Critical patent/BRPI0416928A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/10—1,4-Thiazines; Hydrogenated 1,4-thiazines
    • C07D279/14—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems
    • C07D279/18—[b, e]-condensed with two six-membered rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

"DESENVOLVIMENTOS DE DERIVADOS BIOLOGICAMENTE ATIVOS DE AZUL DE METILENO". Um composto fenotiazina de Fórmula (I) para uso como um agente antimicrobiano para a prevenção de infecções microbianas em que: cada R1, R2, R3 e R4 independentemente é um substituto opcionalmente linear, ramificado ou grupo hidrocarbono cíclico; ou R1 e R2 ou R3 e R4 juntos com o átomo de N ao qual eles estão ligados formam um anel de 5-, 6- ou 7- membros opcionalmente substituídos; X¬ p-¬ é um contra íon; e P é 1, 2 ou 3. A invenção também relaciona-se a composições compreendendo compostos fenotiazina para selecionar compostos e seu uso como medicamentos, como agentes PDT, como agentes fotodiagnósticos, para um conjugato ou compósite formada entre um fenotiazina e um polímero; e a um método para esterilizar fluidos em que o fluido passa através do conjugado ou compósite enquanto ele é iluminado. Os compostos são fotossensibilizantes biologicamente ativos que são fortemente fotocitotóxicos e têm aplicação nas áreas de terapia fotodinâmica (PDT), bem como para o diagnóstico e detecção de condições médicas e usos relacionados em internalização fotoquímica, na produção de vacinas de câncer, no tratamento e prevenção de infecções microbianas e em fotodesinfecção ou fotoesterilização.
BRPI0416928-0A 2003-11-28 2004-11-22 desenvolvimento de derivados biologicamente ativos de azul de metileno BRPI0416928A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0327672.2A GB0327672D0 (en) 2003-11-28 2003-11-28 Developments in biologically active methylene blue derivatives (phenothiazines)
GB0329809A GB0329809D0 (en) 2003-12-23 2003-12-23 Developments in biologically active methylene blue derivatives (2) (phenothiazines)
PCT/GB2004/004918 WO2005054217A1 (en) 2003-11-28 2004-11-22 Developments in biologically active methylene blue derivatives (2)

Publications (1)

Publication Number Publication Date
BRPI0416928A true BRPI0416928A (pt) 2007-01-16

Family

ID=34655223

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0416928-0A BRPI0416928A (pt) 2003-11-28 2004-11-22 desenvolvimento de derivados biologicamente ativos de azul de metileno

Country Status (7)

Country Link
EP (1) EP1687286A1 (pt)
JP (1) JP2007512297A (pt)
KR (1) KR20060111536A (pt)
AU (1) AU2004295148A1 (pt)
BR (1) BRPI0416928A (pt)
CA (1) CA2547556A1 (pt)
WO (1) WO2005054217A1 (pt)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7176308B2 (en) * 2002-06-17 2007-02-13 Verification Technologies, Inc. Processes for preparing novel methylene blue derivative
EP1799662B1 (en) 2004-09-23 2013-04-17 Wista Laboratories Ltd. Methods of chemical synthesis and purification of diaminophenothiazinium compounds including methylthioninium chloride (mtc)
US7790881B2 (en) * 2004-09-23 2010-09-07 Wista Laboratories Ltd. Methods of chemical synthesis and purification of diaminophenothiazinium compounds including methylthioninium chloride (MTC)
EP2853293B1 (en) * 2006-03-29 2017-11-22 WisTa Laboratories Ltd. Thioninium compounds and their use
JP5654748B2 (ja) 2006-03-29 2015-01-14 ウイスタ・ラボラトリーズ・リミテッドＷｉｓｔａ Ｌａｂｏｒａｔｏｒｉｅｓ Ｌｔｄ． タンパク質凝集の阻害物質
DE602007008550D1 (de) 2006-03-29 2010-09-30 Wista Lab Ltd 3,7-diamino-10h-phenothiazinsalze und ihre verwendung
EP2457904B1 (en) 2006-07-11 2014-11-19 Wista Laboratories Ltd. Methods of synthesis and/or purification of diaminophenothiazinium compounds
FR2903696B1 (fr) 2006-07-12 2011-02-11 Provence Technologies Procede de purification de composes diaminophenothiazium
CN101631780A (zh) * 2007-04-03 2010-01-20 普罗瑟塔生物谐成公司 用于抗病毒治疗的吩噻嗪衍生物
FR2920775B1 (fr) * 2007-09-07 2009-11-06 Pharma Hydro Dev P H D Soc Par Nouveaux composes diaminophenothiazine, leur procede de preparation et leurs utilisations.
GB2453564A (en) * 2007-10-11 2009-04-15 Liverpool John Moores University Ring-fused derivatives of 3,7-diamino- phenothiazinium & phenoselenazinium salts for use as antimicrobial agents
CN102958525B (zh) * 2010-04-30 2017-05-24 普罗瑟塔抗病毒股份有限公司 抗病毒化合物
WO2012085257A1 (en) * 2010-12-22 2012-06-28 Ortner Cleanroom Engineering Gmbh Photodynamic control of microbial growth on surfaces
EP2654807B1 (en) * 2010-12-22 2017-04-19 Ortner Cleanroom Engineering GmbH Clean room device with movable electromagnetic radiation source
AU2011358840B2 (en) 2011-02-11 2017-05-04 TauRx Therapeutics Management Ltd Phenothiazine diaminium salts and their use
WO2012125983A1 (en) 2011-03-17 2012-09-20 Prosetta Antiviral Inc. Antiviral treatments
EP2694478B1 (en) * 2011-04-04 2018-08-22 Arizona Board of Regents, a Body Corporate of the State of Arizona acting for and on behalf of Arizona State University Methylene violet analogs as multifunctional radical quenchers for the treatment of mitochondrial dysfunction
WO2012145567A1 (en) 2011-04-20 2012-10-26 Prosetta Antiviral Inc. Antiviral compounds
US20120301904A1 (en) 2011-04-26 2012-11-29 Prosetta Antiviral, Inc Multiprotein assemblies
CA2891291A1 (en) 2012-11-12 2014-05-15 Moontunes, Inc. Systems and methods for communicating a live event to users using the internet
KR101741235B1 (ko) * 2013-08-15 2017-05-29 유파마 피티와이 엘티디 디아미노페노티아지니움 화합물을 정제하는 방법
JP6412142B2 (ja) 2014-08-27 2018-10-24 富士フイルム株式会社 光線力学療法用組成物、殺菌方法、殺菌システムおよび殺菌システムの作動方法
WO2017116903A1 (en) 2015-12-28 2017-07-06 Frangioni, John, V. Method of preparing diaminophenothiazinium
FR3063495B1 (fr) * 2017-03-02 2019-04-05 Provepharm Life Solutions Procede de preparation de l’iodure de 3,7-bis(dimethylamino)phenothiazine-5-ylium
CA3072418A1 (en) * 2017-08-08 2019-02-14 Board Of Trustees Of Michigan State University Tunable luminescent organic salts for enhanced imaging and photodynamic therapy
US12215234B2 (en) 2019-09-21 2025-02-04 RK Pharma Solutions LLC Process for the purification of methylene blue

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2794786A (en) * 1955-05-27 1957-06-04 Security Trust Company Thionin dye-ion exchange resin indicator compounds
US3579339A (en) * 1967-05-23 1971-05-18 Du Pont Photopolymerizable dispersions and elements containing nonmigratory photoreducible dyes
US3641016A (en) * 1968-02-16 1972-02-08 Egyt Gyogyszervegyeszeti Gyar Thionine derivatives
FR2196082A5 (pt) * 1972-08-07 1974-03-08 Lucien Internal
US4426446A (en) * 1981-02-03 1984-01-17 Hoffmann-La Roche Inc. Leucocyte adherence inhibition assay for detection of cancer
JPS638652A (ja) * 1986-06-27 1988-01-14 Ricoh Co Ltd 静電荷像現像用トナ−
CS264623B1 (cs) * 1987-06-19 1989-08-14 Capek Antonin Biocidní prostředek
DE69028775T2 (de) * 1989-05-11 1997-05-07 Oklahoma Med Res Found Antivirale therapie unter verwendung von thiazin- und xanthenfarbstoffen
WO1991016911A1 (en) * 1990-05-01 1991-11-14 The American National Red Cross Decontamination of whole blood and cellular components by phenthiazin-5-ium-dyes plus light
US5220009A (en) * 1990-05-03 1993-06-15 Yeda Research And Development Company Limited Phenothiazinium salts and their use for disinfecting aqueous effluents
US5344928A (en) * 1991-04-26 1994-09-06 Takeda Chemical Industries, Ltd. Phenothiazine derivatives, their production and use
US5527704A (en) * 1994-12-06 1996-06-18 Baxter International Inc. Apparatus and method for inactivating viral contaminants in body fluids
US5830526A (en) * 1994-12-28 1998-11-03 Fibermark, Inc. Light-activated antimicrobial and antiviral materials
DE19640722A1 (de) * 1996-10-02 1998-04-23 Stiftung Fuer Lasertechnologie Verfahren und Vorrichtung zur Zell- und Gewebezerstörung durch Methylen Blau (MB+) in Verbindung mit polychromatischem Licht im roten Frequenzbereich
DE19640758C2 (de) * 1996-10-02 1999-11-04 Rafael Lachky Mittel zur Behandlung von Diskusfischen
US6190609B1 (en) * 1996-11-19 2001-02-20 Baxter International Inc. Methods and apparatus for inactivating contaminants in biological fluid
CA2298526A1 (en) * 1997-07-28 1999-02-04 Dermatolazer Technologies Ltd Phototherapy based method for treating pathogens and composition for effecting same
US5811471A (en) * 1997-09-15 1998-09-22 Shanbrom Technologies Llc Disinfectant plastic sponge material
AU3371799A (en) * 1998-03-30 1999-10-18 Fibermark, Inc. Light-activated antimicrobial polymeric materials
AUPP751298A0 (en) * 1998-12-04 1999-01-07 Csl Limited Inactivation of non-enveloped viruses
WO2000041725A2 (en) * 1999-01-15 2000-07-20 Light Sciences Corporation Therapeutic compositions for metabolic bone disorders or bone metastases
RU2184737C2 (ru) * 1999-02-23 2002-07-10 Институт нефтехимии и катализа АН РБ и УНЦ РАН Органические комплексы цефалоспориновых антибиотиков, обладающие антимикробными свойствами
AU2461001A (en) * 2000-01-05 2001-07-16 American National Red Cross, The Photodynamic inactivation of pathogens in blood by phenothiazines and oxygen
GB0002719D0 (en) * 2000-02-08 2000-03-29 Tissuemed Ltd Thermal ablation of tissue
RU2176505C2 (ru) * 2000-02-15 2001-12-10 Третьяков Василий Васильевич Средство, обладающее противовирусной активностью, на основе соединений серебра и золота с тиазином и способ его получения
WO2001062289A2 (en) * 2000-02-26 2001-08-30 Advanced Photodynamic Technologies, Inc. Photodynamic cellular and acellular organism eradication utilizing a photosensitive material and surfactant
JP2004502704A (ja) * 2000-06-30 2004-01-29 ジラ・インク 上皮癌の検出のためのメチレンブルー診断剤および診断方法
US6881731B1 (en) * 2000-10-23 2005-04-19 Shanbrom Technologies, Llc Enhancers for microbiological disinfection
US6623513B2 (en) * 2001-01-19 2003-09-23 Advanced Photodynamic Technologies, Inc. Apparatus and method of photodynamic eradication of organisms utilizing pyrrolnitrin
GB0113121D0 (en) * 2001-05-30 2001-07-18 Univ Leeds Biologically active photosensitisers
RU2209072C2 (ru) * 2001-09-25 2003-07-27 Орловский Евгений Владимирович Антивирусная композиция для лечения вич-инфицированных больных с высокой вирусной нагрузкой

Also Published As

Publication number Publication date
WO2005054217A1 (en) 2005-06-16
AU2004295148A1 (en) 2005-06-16
CA2547556A1 (en) 2005-06-16
EP1687286A1 (en) 2006-08-09
KR20060111536A (ko) 2006-10-27
JP2007512297A (ja) 2007-05-17

Similar Documents

Publication Publication Date Title
BRPI0416928A (pt) desenvolvimento de derivados biologicamente ativos de azul de metileno
ES2565991T3 (es) Composición terapéutica y uso
Kawczyk-Krupka et al. Photodynamic therapy as an alternative to antibiotic therapy for the treatment of infected leg ulcers
BRPI0212172A8 (pt) agente fotossensibilizante ou um sal farmaceuticamente aceitável do mesmo, processo para a preparação do mesmo, composição farmacêutica, uso do dito agente ou de um sal farmaceuticamente aceitável do mesmo, método para a introdução de uma molécula de transferência no citosol de uma célula, método para tratamento fotoquimioterapêutico de distúrbios ou anormalidades de superfícies externas ou internas do corpo, produto, kit para uso em fotoquimioterapia de distúbios ou anormalidades de superfícies externas ou internas do corpo, e, método para diagnose in vitro de anormalidades ou distúrbios através da análise de uma amostra do fluido do corpo ou do tecido de um paciente
BRPI0412343A (pt) derivados de piridazina e seu uso como agentes terapêuticos
BR0113358A (pt) Derivado de quinazolina ou de um seu sal farmaceuticamente aceitável, processo para a sua preparação, composição farmacêutica, e, uso do derivado ou de um seu sal farmaceuticamente aceitável
BR9807055A (pt) Composição farmacêutica, uso de um agente fotoquimioterapêutico precursor da protoporfirina junto com um fotossensibilizador de localização de estroma vascular, produto contendo os mesmos, kit para uso em fotoquimioterapia de distúrbios ou anormalidades das superfìcies externa ou interna do corpo, e, processos de tratamento fotoquimioterapêutico de distúrbios ou anormalidades de superfìcies externa ou interna do corpo, e de diagnóstico in vitro de anormalidades ou distúrbios, mediante ensaios de uma amostra de fluidos corporais ou tecidos de um paciente
BR0208678A (pt) Composto, composição farmacêutica, uso de um composto
CY1108583T1 (el) Μεθοδος για θεραπεια σοβαρης καρδιακης ανεπαρκειας και φαρμακο για αυτη
SV2002000245A (es) Oxazolidinonas substituidas y su uso ref. lea 34122-sv
BR0312513A (pt) Derivados de glicosìdeo de tiofeno, processos para a produção dos mesmos, medicamentos que contêm esses compostos e uso dos mesmos
DOP2006000084A (es) Compuestos sulfoximino-macrociclicos y sus sales, composiciones farmaceuticas que comprenden dichos compuestos, metodos de preparacion y usos de los mismos
CY1109120T1 (el) Φαρμακευτικη συνθεση βινφλουνινης που προοριζεται για παρεντερικη χορηγηση, μεθοδος παρασκευης και χρησης
BR0210034A (pt) Conjunto de partes, método para tratamento de trombose, uso de um composto, formulação farmacêutica, uso e processo para preparação da mesma, e, composto
YU21701A (sh) Farmaceutska sredstva za lečenje parkinsonove bolesti, poremećaja nekontrolisane hiperaktivnosti (adhd) i mikroadenoma
BRPI0414780B8 (pt) composto, uso do mesmo, composição farmacêutica, e, método para preparar um composto
BR0313727A (pt) Derivados de isoquinolina como inibidores de metaloproteinase da matriz
BR0208053A (pt) Sìntese de moléculas isoflavonas diméricas, composições contendo as mesmas e seus usos como agentes terapêuticos
UY28356A1 (es) Derivados de benzimidazol, composiciones que los contienen, preparaciones de los mismos y sus usos
SE0300098D0 (sv) Use of cyclin D1 inhibitors
BRPI0509512A (pt) método de tratar esquizofrenia e/ou anormalidades glicorregulatórias
UY28357A1 (es) Derivados de benzimidazol, composiciones que los contienen, preparación de los mismos y sus usos
BRPI0408689B8 (pt) derivados de benzenosulfonamida, método para preparação e utilização disso para o tratamento da dor
BR0213372A (pt) Medicamento compreendendo combinação de derivado de traizaespiro[5,5]undecano com inibidor de citocromo p450 isozima 3a4 e/ou inibidor de glocoproteìna-p
UY28535A1 (es) Derivados de bencimidazol, composiciones que los contienen, preparacion y usos de los mismos.

Legal Events

Date Code Title Description
B08F Application fees: application dismissed [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 5A, 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2158 DE 15/05/2012.